Arbutus Initiates International Patent Infringement Enforcement Actions Against Pfizer and ...

Arbutus and licensee Genevant filed three international patent infringement lawsuits against Pfizer and BioNTech over lipid nanoparticle (LNP) technology used in COVID-19 vaccines, seeking injunctions and damages across Canada and 20 European countries. The company also received $178M from a Moderna settlement and plans to return approximately $230M to shareholders.

This Wire brief sits within Fusion42's coverage of Digital Health. Wire is Fusion42's founder-focused intelligence feed: each story is connected to the funds and startups it names — every one with a live profile on Raise or Scout — so founders can follow the capital and the momentum behind the headline rather than just the headline itself. Wire analysis is one of the live surfaces Arthur, Fusion42's AI co-founder, reasons over.